Eevia Health Plc Interim Report Q1 - 2024
The Board and CEO of Eevia Health Plc present the Interim Financial Report for quarter 1, 2024.Summary of financial development in Q1-2024 Working to regain profitable revenue growth The year began with net sales landing at KEUR 407, up 28% from KEUR 317 in Q4-23. Still, the sales rate for this quarter were lower than the first three quarters of 2023 and was insufficient to produce positive net results for the quarter with the current cost base. The main reasons for the drop off in sales since first half of 2023 is the halt in orders from our main US customer (almost 75% of turnover